Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
Resource Type
Article
Authors
Madhi, Shabir A ; Koen, Anthonet L ; Izu, Alane ; Fairlie, Lee ; Cutland, Clare L ; Baillie, Vicky ; Padayachee, Sherman D ; Dheda, Keertan ; Barnabas, Shaun L ; Bhorat, Qasim Ebrahim ; Briner, Carmen ; Aley, Parvinder K ; Bhikha, Sutika ; Hermanus, Tandile ; Horne, Elizea ; Jose, Aylin ; Kgagudi, Prudence ; Lambe, Teresa ; Masenya, Masebole ; Masilela, Mduduzi ; Mkhize, Nonhlanhla ; Moultrie, Andrew ; Mukendi, Christian K ; Moyo-Gwete, Thandeka ; Nana, Amit J ; Nzimande, Ayanda ; Patel, Faeezah ; Rhead, Sarah ; Taoushanis, Carol ; Thombrayil, Asha ; van Eck, Samuel ; Voysey, Merryn ; Villafana, Tonya L ; Vekemans, Johan ; Gilbert, Sarah C ; Pollard, Andrew J ; Moore, Penny L ; Kwatra, Gaurav
Source
In The Lancet HIV September 2021 8(9):e568-e580
Subject
Primary Research Articles
Language
ISSN
2352-3018